The therapeutic implications of oestrogens in cardiovascular diseases

Author： Manassiev N.   Rilwan A.   Stevenson J.  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.3, Iss.1, 1998-06, pp. : 173-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diagnostic and Therapeutic Nanoparticles in Cardiovascular Diseases

By  

Current Pharmaceutical Design, Vol. 21, Iss. 42, 2015-12 ,pp. : 6070-6080

Bentham Science Publishers

Access to resources Recommend Favorite

The Genomics of Cardiovascular Disorders: Therapeutic Implications

By Ferrari P.  

Drugs, Vol. 59, Iss. 5, 2000-05 ,pp. : 1025-1042

Adis International

Access to resources Recommend Favorite

Vasopressin in cardiovascular patients: therapeutic implications

By Zimmerman Michael A   Albright Tracy N   Raeburn Christopher D   Selzman Craig H  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. : 505-512

Informa Healthcare

Access to resources Recommend Favorite

Urocortin: Cardiovascular Actions and Therapeutic Implications

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 2, 2004-04 ,pp. : 168-172

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Rho-Kinase Inhibitors in Cardiovascular Diseases

By Hirooka Yoshitaka   Shimokawa Hiroaki  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 31-39

Adis International

Access to resources Recommend Favorite